The 82 references in paper V. DOBRONRAVOV A., В. ДОБРОНРАВОВ А. (2011) “CОВРЕМЕННЫЙ ВЗГЛЯД НА ПАТОФИЗИОЛОГИЮ ВТОРИЧНОГО ГИПЕРПАРАТИРЕОЗА: РОЛЬ ФАКТОРА РОСТА ФИБРОБЛАСТОВ 23 И KLOTHO // CURRENT VIEW ON THE PATHOPHYSIOLOGY OF SECONDARY HYPERPARATHYROIDISM: ROLE OF FIBROBLAST GROWTH FACTOR 23 AND KLOTHO” / spz:neicon:nefr:y:2011:i:4:p:11-20

1
Bricker NS. On the pathogenesis of the uremic state. An exposition of the ‘trade-off hypothesis’. N Engl J Med 1972;
(check this in PDF content)
2
6 (20): 1093–1099 2. Portale AA, Halloran BP, Murphy MM et al. Oral intake of phosphorus can determine the serum concentration of 1,25dihydroxyvitamin D by determining its production rate in humans. J Clin Invest 1986; 77 (1): 7–12
(check this in PDF content)
3
Slatopolsky E, Finch J, Denda M et al. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996; 97 (11): 2534–2540
(check this in PDF content)
4
Slatopolsky E. The intact nephron hypothesis: the concept and its implications for phosphate management in CKD-related mineral and bone disorder. Kidney Int 2011; 79 (Suppl 121): S3-S8
(check this in PDF content)
5
Potts JT. Parathyroid hormone: past and present. J Endocrinol 2005; 187 (3): 311–325
(check this in PDF content)
6
Kumar R, Thompson JR The regulation of parathyroid hormone secretion and synthesis. J Am Soc Nephrol 2011;22(2):216-224
(check this in PDF content)
7
Denda M, Finch J, Slatopolsky E. Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis 1996; 28 (4): 596–602
(check this in PDF content)
8
Martin DR, Ritter CS, Slatopolsky E et al. Acute regulation of parathyroid hormone by dietary phosphate. Am J Physiol Endocrinol Metab 2005; 289 (4): E729–E734
(check this in PDF content)
9
Kestenbaum B, Sampson JN, Rudser KD et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. Journal of the American Society of Nephrology. 2005; 16(2):520–528
(check this in PDF content)
10
Hsu CY, Chertow GM. Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrology Dialysis Transplantation. 2002;17(8):1419–1425
(check this in PDF content)
11
Levin A, Bakris GL, Molitch M et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney International 2007; 71 (1): 31–38
(check this in PDF content)
12
Murayama A, Takeyama K, Kitanaka S et al. Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals. Endocrinology 1999;140(5):2224-2231
(check this in PDF content)
13
Shimada T, Mizutani S, Muto T et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 2001; 98 (11): 6500– 6505
(check this in PDF content)
14
Kurosu H, Ogawa Y, Miyoshi M et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 2006 10;281(10):6120-6123
(check this in PDF content)
15
Kuro-o M, Matsumura Y, Aizawa H et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390(6655): 45–51
(check this in PDF content)
16
Liu S, Vierthaler L, Tang W et al. FGFR3 and FGFR4 do not mediate renal effects of FGF23. J Am Soc Nephrol 2008; 19 (12): 2342–2350
(check this in PDF content)
17
Hu MC, Shi M, Zhang J et al. Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 2010; 24 (9): 3438–3450
(check this in PDF content)
18
Saito H, Kusano K, Kinosaki M et al. Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J Biol Chem 2003; 278 (4): 2206–2211
(check this in PDF content)
19
Shimada T, Hasegawa H, Yamazaki Y et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004; 19(3): 429-435
(check this in PDF content)
20
Аntoniucci DM, Yamashita T, Portale AA: Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 2006; 91 (8): 3144–3149
(check this in PDF content)
21
Burnett SM, Gunawardene SC, Bringhurst FR et al. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 2006; 21 (8): 1187–1196
(check this in PDF content)
22
Lуpez I, Rodrнguez-Ortiz ME, Almadйn Y et al. Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo. Kidney Int 2011; 80 (5): 475–482
(check this in PDF content)
23
Tsujikawa H, Kurotaki Y, Fujimori T et al. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 2003; 17 (12): 2393–2403
(check this in PDF content)
24
Isakova T, Wahl P, Vargas GS et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011; 79 (12): 1370-1378
(check this in PDF content)
25
Gutierrez O, Isakova T, Rhee E et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. Journal of the American Society of Nephrology 2005; 16 (7):2205–2215
(check this in PDF content)
26
Liu S, Quarles LD. How fibroblast growth factor 23 works. Journal of the American Society of Nephrology 2007;18 (6):1637–1647
(check this in PDF content)
27
Priе D, Torres PU, Friedlander G. Latest findings in phosphate homeostasis. Kidney International 2009; 75 (9): 882– 889
(check this in PDF content)
28
Wolf M. Forging forward with 10 burning questions on FGF23 in kidney disease. Journal of the American Society of Nephrology 2010; 21 (9): 1427–1435
(check this in PDF content)
29
Berndt T, Kumar R. Novel mechanisms in the regulation of phosphorus homeostasis. Physiology 2009; 24 (1): 17–25
(check this in PDF content)
30
Berndt T, Thomas LF, Craig TA et al. Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc Natl Acad Sci USA 2007; 104 (26): 11085–11090
(check this in PDF content)
31
Martin DR, Ritter CS, Slatopolsky E et al. Acute regulation of parathyroid hormone by dietary phosphate. Am J Physiol Endocrinol Metab 2005; 289 (4): E729–E734.
(check this in PDF content)
32
Ito N, Fukumoto S, Takeuchi Y et al. Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans. J Bone Miner Metab 2007; 25 (6): 419–422
(check this in PDF content)
33
Isakova T, Gutierrez O, Shah A et al. Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol 2008; 19 (3): 615-623
(check this in PDF content)
34
Cha SK, Ortega B, Kurosu H et al. Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci USA 2008; 105 (28): 9805–9810
(check this in PDF content)
35
Drueke TB. Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation? Kidney Int. 2010; 78 (11): 1057-1060
(check this in PDF content)
36
Imura A, Tsuji Y, Murata M et al. a-Klotho as a regulator of calcium homeostasis. Science 2007; 316 (5831): 1615–1618
(check this in PDF content)
37
Hu MC, Shi M, Zhang J et al. Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 2010; 24 (9): 3438–3450
(check this in PDF content)
38
Hu MC, Shi M, Zhang J et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011; 22 (1): 124–136
(check this in PDF content)
39
Koh N, Fujimori T, Nishiguchi S et al. Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun 2001; 280 (4): 1015–1020
(check this in PDF content)
40
O’Brien SP, Boulanger JH, Liu S et al. Decline in Klotho expression precedes FGF23 and PTH induction in the Jck mouse, a progressive genetic model of CKD-MBD [Abstract F-FC224]. J Am Soc Nephrol 2009; 20: 54A
(check this in PDF content)
41
Kuro-o М. Phosphate and Klotho. Kidney International 2011; 79 (Suppl 121), S20–S23
(check this in PDF content)
42
Sitara D, Razzaque MS, St-Arnaud R et al. Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. Am J Pathol 2006; 169 (6): 2161–2170
(check this in PDF content)
43
Ohnishi M, Nakatani T, Lanske B et al. Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int 2009; 75 (11): 1166–1172
(check this in PDF content)
44
Morishita K, Shirai A, Kubota M et al. The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc. J Nutr 2001; 131 (12): 3182–3188
(check this in PDF content)
45
Stubbs JR, Liu S, Tang W et al. Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol 2007; 18 (7): 2116–2124
(check this in PDF content)
46
Ohnishi M, Nakatani T, Lanske B et al. In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels. Circ Cardiovasc Genet 2009; 2 (6): 583–590
(check this in PDF content)
47
Galitzer H, Ben-Dov IZ, Silver J et al. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int 2010; 77 (3): 211–218
(check this in PDF content)
48
Komaba H, Goto S, Fujii H et al. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 2010; 77 (3): 232–238
(check this in PDF content)
49
Krajisnik T, Olauson H, Mirza MA et al. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients. Kidney Int 2010; 78 (10): 10241032
(check this in PDF content)
50
Krajisnik T, Bjorklund P, Marsell R et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alphahydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 2007; 195: 125–131
(check this in PDF content)
51
Ichikawa S, Imel EA, Kreiter ML et al. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 2007; 117 (9): 2684–2691
(check this in PDF content)
52
Hofman-Bang J, Martuseviciene G, Santini MA et al. Increased parathyroid expression of klotho in uremic rats. Kidney Int 2010; 78 (11): 1119–1127
(check this in PDF content)
53
Wetmore JB, Liu S, Krebill R et al. Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD. CJASN 2010; 5 (1): 110-116
(check this in PDF content)
54
Dusso AS, Pavlopoulos T, Naumovich L et al. p21WAF1 and transforming growth factor-б mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int 2001; 59 (3): 855–865
(check this in PDF content)
55
Wells A. EGF receptor. Int J Biochem Cell Biol 1999; 31: 637–643
(check this in PDF content)
56
Cozzolino M, Lu Y, Sato T et al. A critical role for enhanced TGF-a and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease. Am J Physiol Renal Physiol 2005; 289 (5): F1096–F1102
(check this in PDF content)
57
Raught B, Gingras AC, James A et al. Expression of a translationally regulated, dominant-negative CCAAT/enhancerbinding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells. Cancer Res 1996; 56 (19): 4382–4386
(check this in PDF content)
58
Arcidiacono MV, Sato T, Alvarez-Hernandez D et al. EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease. J Am Soc Nephrol 2008; 19 (2): 310-320
(check this in PDF content)
59
Dusso A, Arcidiacono MV, Yang J et al. Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality. J Steroid Biochem Mol Biol 2010; 121 (1-2): 193–198
(check this in PDF content)
60
Chen CD, Podvin S, Gillespie E et al. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci USA 2007; 104 (50): 19796–19801
(check this in PDF content)
61
Bloch L, Sineshchekova O, Reichenbach D et al. Klotho is a substrate for a-, в- and г-secretase. FEBS Lett 2009; 583 (19): 3221–3224
(check this in PDF content)
62
Chen CD, Podvin S, Gillespie E et al. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci USA 2007; 104 (50): 19796–19801
(check this in PDF content)
63
Cordero JB, Cozzolino M, Lu Y et al. 1,25Dihydroxyvitamin D down-regulates cell membrane growthand nuclear growth-promoting signals by the epidermal growth factor receptor. J Biol Chem 2002; 277 (41): 38965–38971
(check this in PDF content)
64
Dusso A. Kidney disease and vitamin D levels: 25hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation. Kidney Int 2011; Suppl. 1: 136-141
(check this in PDF content)
65
Tatsumi S, Segawa H, Morita K et al. Molecular cloning and hormonal regulation of PiT-1, a sodium-dependent phosphate cotransporter from rat parathyroid glands. Endocrinology 1998; 139 (4):1692-1699
(check this in PDF content)
66
Jiang Y, Wang M. Overexpression of parathyroid pituitary-specific transcription factor (Pit)-1 in hyperphosphatemia-induced hyperparathyroidism of chronic renal failure rats. Chin Med J (Engl) 2010;123 (12): 1566-1570
(check this in PDF content)
67
Fliser D, Kollerits B, Never U et al. Fibroblast growth factor 23 (FGF-23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 2007; 18 (9): 2600–2608
(check this in PDF content)
68
Titan SM, Zatz R, Graciolli FG et al. FGF-23 as a predictor of renal outcome in diabetic nephropathy. Clin J Am Soc Nephrol 2010; 6 (2): 241–247
(check this in PDF content)
69
Vervloet M, van Zuilen AD, Blankenstijn PJ et al. Fibroblast growth factor 23 is associated with proteinuria. J Am Soc Nephrol 2010; 21: 186A
(check this in PDF content)
70
Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359 (6): 584–592
(check this in PDF content)
71
Vervloet M, Larsson T. Fibroblast growth factor-23 and Klotho in chronic kidney disease. Kidney Int 2011; Suppl. 1: 130-135
(check this in PDF content)
72
Mirza MA, Larsson A, Lind L et al. Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 2009; 205 (2): 385–390
(check this in PDF content)
73
Mirza MA, Hansen T, Johansson L et al. Relationship between circulating FGF-23 and total body atherosclerosis in the community. Nephrol Dial Transplant 2009; 24 (10): 3125– 3131
(check this in PDF content)
74
Yilmaz MI, Sonmez A, Saglam M et al. FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int 2010; 78 (7): 679–685
(check this in PDF content)
75
Kirkpantur A, Balci M, Gurbuz CA et al. Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients. Nephrol Dial Transplant 2011; 26 (4): 1346–1354
(check this in PDF content)
76
Kuro-o M. Klotho as a regulator of oxidative stress and senescence. Biol Chem 2008; 389 (3): 233–241
(check this in PDF content)
77
Kusaba T, Okigawa M, Matui A et al. Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity. Proc Natl Acad Sci USA 2010; 107 (45): 19308–19313
(check this in PDF content)
78
Nagai R, Saito Y, Ohyama Y et al. Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases. Cell Mol Life Sci 2000; 57 (5): 738–746
(check this in PDF content)
79
Doi S, Zou Y, Togao O et al. Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem 2011; 286 (10): 8655–8665
(check this in PDF content)
80
Takeshita K, Fujimori T, Kurotaki Y et al. Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 2004; 109 (14): 1776– 1782
(check this in PDF content)
81
Maschio G, Tessitore N, D’Angelo A et al. Early dietary phosphorus restriction and calcium supplementation in the prevention of renal osteodystrophy. Am J Clin Nutr 1980; 33 (7): 1546–1554
(check this in PDF content)
82
Alfrey AC: Effect of dietary phosphate restriction on renal function and deterioration. Am J Clin Nutr 1988; 47 (1): 153–156 Ïîñòóïèëà â ðåäàêöèþ 27.10.2011 ã. Ïðèíÿòà â ïå÷àòü 18.11.2011 ã.
(check this in PDF content)